product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
DNA-PK Antibody
catalog :
4602
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, western blot knockout validation
more info or order :
citations: 6
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| Hong X, Liu W, Song R, Shah J, Feng X, Tsang C, et al. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Res. 2016;44:8855-8869 pubmed
|
| |
product information
SKU :
4602P
Product-Name :
DNA-PK Antibody
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
450
Host :
Rabbit
Target :
DNA-PK
Primary-Protein :
DNA-PK
Alt-Names :
DNA-PK catalytic subunit,DNA-PKcs,DNA-dependent protein kinase catalytic subunit,DNAPK,DNPK1,HYRC,HYRC1,PRKDC,XRCC7,hyper-radiosensitivity of murine scid mutation, complementing 1,p350,p460,protein kinase, DNA-activated, catalytic polypeptide
more info or order :
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
related products
browse more products
questions and comments